Although the accumulating evidences suggest that CD103 is involved in the pathogenesis of some immune-mediated diseases such as GVHD, asthma, and allergic contact hypersensitivity, how CD103 controls immune responses leading to the development of cutaneous inflammatory disorders remains unclear. The gene discussed is ITGAE; the disease is graft versus host disease.